metricas
Medicina Clínica (English Edition) Adverse reactions to pembrolizumab in patients with cancer
Journal Information
Vol. 166. Issue 1.
(January 2026)
Scientific letter

Adverse reactions to pembrolizumab in patients with cancer

Reacciones adversas a pembrolizumab en pacientes con cáncer
Visits
173
Sara Rodríguez Arboleyaa,
Corresponding author
sara039264@hotmail.com

Corresponding author.
, Alba Vegas Tapiaa, Eva Fonseca Aizpurub, Ruben Pampin Sánchezc
a Medicina Interna, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain
b Medicina Interna (Sección Enfermedades Autoinmunes y Sistémicas), Hospital Universitario de Cabueñes, Gijón, Asturias, Spain
c Farmacología, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools